Xu Liu

机构：Hong Kong University of Science and Technology · ORCID：0009-0002-3286-7090

发表论文 40 篇 · 总被引 938 次 · h-index 12

代表论文

• Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus (2016 · Nature Medicine · 被引 577)
• Changes in Disease Failure Risk of Nasopharyngeal Carcinoma over Time: Analysis of 749 Patients with Long-Term Follow-Up (2017 · Journal of Cancer · 被引 59)
• Spontaneous remission of residual post‐therapy plasma Epstein–Barr virus DNA and its prognostic implication in nasopharyngeal carcinoma: A large‐scale, big‐data intelligence platform‐based analysis (2018 · International Journal of Cancer · 被引 39)
• Prevalence of Cardiovascular Comorbidities in Coronavirus Disease 2019, Severe Acute Respiratory Syndrome, and Middle East Respiratory Syndrome: Pooled Analysis of Published Data (2020 · Journal of the American Heart Association · 被引 30)
• Clinical features and underlying genetic causes in neonatal encephalopathy: A large cohort study (2020 · Clinical Genetics · 被引 25)
• Combining tumor response and personalized risk assessment: Potential for adaptation of concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma in the intensity-modulated radiotherapy era (2020 · Radiotherapy and Oncology · 被引 23)